Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy

Obeso, J.A., Stamelou, M., Goetz, C.G., Poewe, W., Lang, A.E., Weintraub, D., Burn, D., Halliday, G.M. +30 more·2017·Movement Disorders

Cited by (736)

Items 201–300 of 736

  1. Novel insights into the role of circular RNAs in Parkinson disease: An emerging renaissance in the management of neurodegenerative diseases
    Zahra Dorostgou, Negar Yadegar, Zeynab Dorostgou, Fariborz Khorvash, Omid Vakili · 2022 · Journal of Neuroscience Research
  2. Validation of a Spatiotemporal Gait Model Using Inertial Measurement Units for Early-Stage Parkinson’s Disease Detection During Turns
    Yifan Yang, Lei Chen, Jun Pang, Xiayu Huang, Lin Meng, Dong Ming · 2022 · IEEE Transactions on Biomedical Engineering
  3. The Role of Tau beyond Alzheimer’s Disease: A Narrative Review
    Eleonora Virgilio, Fabiola De Marchi, Elena Contaldi, Umberto Dianzani, Roberto M. Cantello, Letizia Mazzini, Cristoforo Comi · 2022 · Biomedicines
  4. Melatonin and regulation of autophagy: Mechanisms and therapeutic implications
    Jinjing Wu, Yang Bai, Yaguang Wang, Jun Ma · 2020 · Pharmacological Research
  5. LRRK2 G2019S kinase activity triggers neurotoxic NSF aggregation
    F. Pischedda, M. Cirnaru, L. Ponzoni, M. Sandre, Alice Biosa, M. P. Carrion, O. Marin, M. Morari, L. Pan, E. Greggio et al. · 2019 · bioRxiv
  6. Motor function and the probability of prodromal Parkinson's disease in older adults
    Maria I. Maraki, Leonidas Stefanis, Mary Yannakoulia, Mary H. Kosmidis, Georgia Xiromerisiou, Efthimios Dardiotis, Georgios M. Hadjigeorgiou, Paraskevi Sakka, Nikolaos Scarmeas, María Stamelou · 2019 · Movement Disorders
  7. What's in a Name? The Time Has Come to Unify Parkinson's Disease and Dementia with Lewy Bodies
    Daniel A. Weintraub · 2023 · Movement Disorders
  8. Glucocerebrosidase Mutations Cause Mitochondrial and Lysosomal Dysfunction in Parkinson’s Disease: Pathogenesis and Therapeutic Implications
    Wei Zheng, Dong-Sheng Fan · 2022 · Frontiers in Aging Neuroscience
  9. SINEUPs: a novel toolbox for RNA therapeutics
    Stefano Espinoza, Carlotta Bon, Paola Valentini, Bianca Pierattini, Abraham Tettey‐Matey, Devid Damiani, Salvatore Pulcrano, Remo Sanges, Francesca Persichetti, Hazuki Takahashi et al. · 2021 · Essays in Biochemistry
  10. Altered Dynamic Information Flow through the Cortico-Basal Ganglia Pathways Mediates Parkinson’s Disease Symptoms
    Satomi Chiken, Masahiko Takada, Atsushi Nambu · 2021 · Cerebral Cortex
  11. Stretchable triboelectric sensor for measurement of the forearm muscles movements and fingers motion for Parkinson's disease assessment and assisting technologies
    David Vera Anaya, M. Yuce · 2020 · Medical Devices & Sensors
  12. LRRK2 at the pre‐synaptic site: A 16‐years perspective
    Francesca Pischedda, Giovanni Piccoli · 2020 · Journal of Neurochemistry
  13. Non-toxic HSC Transplantation-Based Macrophage/Microglia-Mediated GDNF Delivery for Parkinson’s Disease
    Cang Chen, Michael J. Guderyon, Yang Li, Guo Ge, Anindita Bhattacharjee, Cori Ballard, Zhixu He, Eliezer Masliah, Robert A. Clark, Jason C. O’Connor et al. · 2019 · Molecular Therapy — Methods & Clinical Development
  14. Targeting 5-HT Is a Potential Therapeutic Strategy for Neurodegenerative Diseases
    Cencan Xing, Hongyu Chen, Wangyu Bi, Tong Lei, Zhongci Hang, Hongwu Du · 2024 · International Journal of Molecular Sciences
  15. Recent advances of nanomaterials for intervention in Parkinson’s disease in the context of anti-inflammation
    Ruoyu Zhang, Xiaotong Chen, Yuanyuan Cheng, Zixuan Chen, Xiaoqiong Li, Yulin Deng · 2023 · Coordination Chemistry Reviews
  16. Glutamatergic Neurons in the Caudal Zona Incerta Regulate Parkinsonian Motor Symptoms in Mice
    Lixuan Li, Yulan Li, Jintao Wu, Jizhou Song, Xiao‐Ming Li · 2021 · Neuroscience Bulletin
  17. Parkinson’s disease and translational research
    Elisabeth Dinter, Theodora Saridaki, Leonie Diederichs, Heinz Reichmann, Björn H. Falkenburger · 2020 · Translational Neurodegeneration
  18. Motor asymmetry related cerebral perfusion patterns in Parkinson's disease: An arterial spin labeling study
    Song’an Shang, Jingtao Wu, Hongying Zhang, Hongri Chen, Zhengye Cao, Yu‐Chen Chen, Xindao Yin · 2020 · Human Brain Mapping
  19. Effect of repetitive transcranial magnetic stimulation on gait and freezing of gait in Parkinson's disease: a systematic review and meta-analysis.
    Yun-Juan Xie, Qiang Gao, Cheng-Qi He, Rong Bian · 2020 · Archives of Physical Medicine and Rehabilitation
  20. The enteric nervous system in PD: gateway, bystander victim, or source of solutions
    Kathleen M. Shannon, Pieter Vanden Berghe · 2018 · Cell and Tissue Research
  21. Recent Trends in the Use of Electrical Neuromodulation in Parkinson’s Disease
    John‐Stuart Brittain, Hayriye Cagnan · 2018 · Current Behavioral Neuroscience Reports
  22. Subjective cognitive decline in patients with Parkinson’s disease: an updated review
    Juan Huang, Xingxing Yuan, Lin Chen, Binbin Hu, Lijuan Jiang, Ting Shi, Hui Wang, Wei Huang · 2023 · Frontiers in Aging Neuroscience
  23. Update on the application of mesenchymal stem cell-derived exosomes in the treatment of Parkinson's disease: A systematic review
    Shufen Liu, Linyi Li, Jian-long Zhuang, Mi-mi Li, Lichao Ye, Xiangrong Chen, Shu Lin, Chunnuan Chen · 2022 · Frontiers in Neurology
  24. Mutation analysis of TMEM family members for early-onset Parkinson’s disease in Chinese population
    Chunyu Li, Ruwei Ou, Yongping Chen, Xiaojing Gu, Qianqian Wei, Bei Cao, Lingyu Zhang, Yanbing Hou, Kuncheng Liu, Xueping Chen et al. · 2020 · Neurobiology of Aging
  25. Parkinson's disease: Evolution of the scientific literature from 1983 to 2017 by countries and journals.
    C. Robert, C. S. Wilson, R. Lipton, C. Arreto · 2019 · Parkinsonism & Related Disorders
  26. Dopaminergic neuronal death via necroptosis in Parkinson's disease: A review of the literature
    Maria Regoni, Flavia Valtorta, Jenny Sassone · 2023 · European Journal of Neuroscience
  27. Single-Cell Sequencing in Neurodegenerative Disorders
    Jelena Pozojevic, Malte Spielmann · 2023 · Molecular Diagnosis & Therapy
  28. The role of frailty in Parkinson’s disease: a cross-sectional study
    Daniele Belvisi, Marco Canevelli, Matteo Costanzo, Margherita Giangrosso, Andrea Fabbrini, Andrea Borraccino, Giuseppe Bruno, Alfredo Berardelli, Giovanni Fabbrini · 2021 · Journal of Neurology
  29. Neuroprotective effects of coenzyme Q10 in Parkinson's model via a novel Q10/miR-149-5p/MMPs pathway
    Elham Ghasemloo, Hossein Mostafavi, Masoumeh Hosseini, Meysam Forouzandeh, Mehdi Eskandari, Seyyed Saeid Mousavi · 2021 · Metabolic Brain Disease
  30. Serum lipid profile among sporadic and familial forms of Parkinson’s disease
    D. Macías-García, M. Periñán, L. Muñoz-Delgado, María del Valle Jiménez-Jaraba, M. Labrador-Espinosa, S. Jesús, D. Buiza-Rueda, Carlota Méndez-Del Barrio, A. Adarmes-Gómez, P. Gómez-Garre et al. · 2021 · npj Parkinson's Disease
  31. Lower Urinary Tract and Gastrointestinal Dysfunction Are Common in Early Parkinson’s Disease
    Daniel Martínez-Ramírez, Edna Sophia Velázquez-Ávila, Alejandro Almaraz-Espinoza, Arnulfo González‐Cantú, Genaro Vázquez‐Elizondo, Daniel Olvera‐Posada, Amin Cervantes‐Arriaga, Mayela Rodríguez‐Violante, Mirna González‐González · 2020 · Parkinson s Disease
  32. A Prospective Validation of the Updated Movement Disorders Society Research Criteria for Prodromal Parkinson's Disease
    Nikolaos Giagkou, Maria I. Maraki, Mary Yannakoulia, Mary H. Kosmidis, Efthimios Dardiotis, Georgios M. Hadjigeorgiou, Paraskevi Sakka, Eva Ntanasi, Costas Anastasios Anastasiou, Georgia Xiromerisiou et al. · 2020 · Movement Disorders
  33. Progress in circRNA-Targeted Therapy in Experimental Parkinson’s Disease
    2023
  34. Effects of non-invasive brain stimulation on walking and balance ability in Parkinson’s patients: A systematic review and meta-analysis
    XinXin Zhang, Fei-Yue Jing, Yu'ang Liu, Jinyong Tang, Xian-Feng Hua, Jialin Zhu, Hao‐Ran Tuo, Qi-zhan Lin, Pin-Cao Gao, Weiguo Liu · 2023 · Frontiers in Aging Neuroscience
  35. A Focus on Astrocyte Contribution to Parkinson’s Disease Etiology
    Giselle Prunell, Silvia Olivera‐Bravo · 2022 · Biomolecules
  36. New Targets and New Technologies in the Treatment of Parkinson’s Disease: A Narrative Review
    Nicola Montemurro, Nelida Aliaga, Pablo Graff, Amanda Escribano, Jafeth Lizana · 2022 · International Journal of Environmental Research and Public Health
  37. Rabphilin-3A as a novel target to reverse α-synuclein-induced synaptic loss in Parkinson’s disease
    Elena Silvia Ferrari, Diego Scheggia, Elisa Zianni, Maria Italia, Marta Brumana, Luca Palazzolo, Chiara Parravicini, Andrea Pilotto, Alessandro Padovani, Elena E. Marcello et al. · 2022 · Pharmacological Research
  38. Neuroprotective Activities of Crossyne flava Bulbs and Amaryllidaceae Alkaloids: Implications for Parkinson’s Disease
    Sylvester Ifeanyi Omoruyi, Abobaker S. Ibrakaw, Okobi Eko Ekpo, J.S. Boatwright, Christopher N. Cupido, Ahmed Abdullah Hussein · 2021 · Molecules
  39. Neuropathological correlation supports automated image-based differential diagnosis in parkinsonism
    K. Schindlbeck, Deepak K. Gupta, Chris C. Tang, Sarah A. O'Shea, K. Poston, Yoon Young Choi, V. Dhawan, J. Vonsattel, S. Fahn, D. Eidelberg · 2021 · European Journal of Nuclear Medicine and Molecular Imaging
  40. Forkhead Box O3a requires BAF57, a subunit of chromatin remodeler SWI/SNF complex for induction of p53 up‐regulated modulator of apoptosis (Puma) in a model of Parkinson’s disease
    Priyankar Sanphui, Anoy Kumar Das, Subhas Chandra Biswas · 2020 · Journal of Neurochemistry
  41. Fingolimod (FTY720) is not protective in the subacute MPTP mouse model of Parkinson's disease and does not lead to a sustainable increase of brain‐derived neurotrophic factor
    Daniel Komnig, Toruntay Cem Dagli, Pardes Habib, Thomas Zeyen, Jörg Bernhard Schulz, Björn H. Falkenburger · 2018 · Journal of Neurochemistry
  42. Most recent advances and applications of extracellular vesicles in tackling neurological challenges
    Mandeep Kaur, Salvatore Fusco, Bram Van den Broek, Jaya Aseervatham, Abdolmohamad M. Rostami, Lorraine Iacovitti, Claudio Grassi, Barbara Łukomska, Amit K. Srivastava · 2024 · Medicinal Research Reviews
  43. Integrative Brain States Facilitate the Expression of Parkinson's Tremor
    Michiel F. Dirkx, James M. Shine, Rick C. G. Helmich · 2023 · Movement Disorders
  44. Targeting Mitochondria as a Therapeutic Approach for Parkinson’s Disease
    Maryam Abrishamdar, Maryam Sadat Jalali, Yaghoob Farbood · 2022 · Cellular and Molecular Neurobiology
  45. Bioengineered models of Parkinson’s disease using patient-derived dopaminergic neurons exhibit distinct biological profiles in a 3D microenvironment
    Nicholas J. Fiore, Yosif M. Ganat, Kapil Devkota, Rebecca Batorsky, Ming Lei, Kyongbum Lee, Lenore Cowen, Gist F. Croft, Scott Noggle, Thomas J.F. Nieland et al. · 2022 · Cellular and Molecular Life Sciences
  46. Proteomic Characterization of Synaptosomes from Human Substantia Nigra Indicates Altered Mitochondrial Translation in Parkinson’s Disease
    Sarah Plum, Britta Eggers, Stefan Helling, Markus Stepath, Carsten Theiß, Renata Elaine Paraízo Leite, Mariana Molina, Lea T. Grinberg, Peter Franz Riederer, Manfred Gerlach et al. · 2020 · Cells
  47. Gender Differences in Neurodegeneration, Neuroinflammation and Na+-Ca2+ Exchangers in the Female A53T Transgenic Mouse Model of Parkinson’s Disease
    Giulia Costa, Maria Josè Sisalli, Nicola Simola, Salvatore Della Notte, Maria Antonietta Casu, Marcello Serra, Annalisa Pinna, Antonio Feliciello, Lucio Annunziato, Antonella Scorziello et al. · 2020 · Frontiers in Aging Neuroscience
  48. Noninvasive intervention by transcranial ultrasound stimulation: Modulation of neural circuits and its clinical perspectives
    Takahiro Osada, Seiki Konishi · 2024 · Psychiatry and Clinical Neurosciences
  49. Effectiveness of different exercises in improving postural balance among Parkinson's disease patients: a systematic review and network meta-analysis
    Di Wang, Wen J. Cui, Zhen H. Hou, Ying Gao · 2023 · Frontiers in Aging Neuroscience
  50. Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson’s disease
    Saül Martínez‐Horta, Helena Bejr‐Kasem, Andrea Horta‐Barba, Berta Pascual‐Sedano, Diego Santos‐García, Teres de Deus-Fonticoba, Silvia Jesús, Miquel Aguilar, Lluís Planellás, Juan García‐Caldentey et al. · 2021 · BMC Neurology
  51. Combined 5-HT2A and mGlu2 modulation for the treatment of dyskinesia and psychosis in Parkinson's disease
    Cynthia Kwan, Imane Frouni, Stephen G. Nuara, Sébastien Belliveau, Woojin Kang, Adjia Hamadjida, Dominique Bédard, Francis Beaudry, Michel Panisset, Jim C. Gourdon et al. · 2021 · Neuropharmacology
  52. Inflammatory lncRNA AK039862 regulates paraquat-inhibited proliferation and migration of microglial and neuronal cells through the Pafah1b1/Foxa1 pathway in co-culture environments.
    Yinyin Zhang, Wen-Ya Shao, Jing-Wen Wu, Shou-Xiong Huang, Hongyu Yang, Zhou-Song Luo, Fu-Li Zheng, Yuan-Liang Wang, Ping Cai, Zhen-Kun Guo et al. · 2020 · Ecotoxicology and Environmental Safety
  53. Single-cell sequencing of the human midbrain reveals glial activation and a neuronal state specific to Parkinson’s disease
    Semra Smajić, Cesar A. Prada‐Medina, Zied Landoulsi, Carola Dietrich, Javier Jarazo, Jana Henck, Saranya Balachandran, Sinthuja Pachchek, Christopher M. Morris, Paul M. A. Antony et al. · 2020 · medRxiv
  54. Post-GWAS knowledge gap: the how, where, and when
    Steven E. Pierce, Alix Booms, Jordan D Prahl, Edwin J. C. Van der Schans, Trevor Tyson, Gerhard A. Coetzee · 2020 · npj Parkinson s Disease
  55. Clinical application of single‐cell RNA sequencing in disease and therapy
    Aisha Shigna Nadukkandy, Sowmiya Kalaiselvan, Lin Lin, Yonglun Luo · 2025 · Clinical and Translational Medicine
  56. Gene Expression Profiling of Post Mortem Midbrain of Parkinson’s Disease Patients and Healthy Controls
    Michele Salemi, Maria Ravo, Giuseppe Lanza, Francesca A. Schillaci, Giovanna Maria Ventola, Giovanna Marchese, Maria Grazia Salluzzo, Graziella Cappelletti, Raffaele Ferri · 2024 · International Journal of Molecular Sciences
  57. Chemogenetic and optogenetic stimulation of zona incerta GABAergic neurons ameliorates motor impairment in Parkinson’s disease
    Feng-Hua Chen, Junliang Qian, Zhong-Kai Cao, Ang Li, Juntao Cui, Li-Min Shi, Jun-Xia Xie · 2023 · iScience
  58. Neurocognitive Psychiatric and Neuropsychological Alterations in Parkinson’s Disease: A Basic and Clinical Approach
    Héctor González-Usigli, Genaro Gabriel Ortíz, Claudia Charles‐Niño, Mario Alberto Mireles-Ramírez, Fermín Paúl Pacheco-Moisés, Blanca Miriam Torres-Mendoza, José J. Hernández-Cruz, Daniela L. C. Delgado-Lara, Luis Javier Ramírez-Jirano · 2023 · Brain Sciences
  59. “Reframing” dopamine signaling at the intersection of glial networks in the aged Parkinsonian brain as innate Nrf2/Wnt driver: Therapeutical implications
    Bianca Marchetti, Carmela Giachino, Cataldo Tirolo, Maria Francesca Serapide · 2022 · Aging Cell
  60. Hallucinations, Delusions and Impulse Control Disorders in Parkinson Disease
    Karlo J. Lizárraga, Susan Helen Fox, Antonio P. Strafella, Anthony Edward Lang · 2019 · Clinics in Geriatric Medicine
  61. Preliminary study of hsa-miR-626 change in the cerebrospinal fluid of Parkinson’s disease patients
    Lixia Qin, Jieqiong Tan, Hainan Zhang, Jianguang Tang, Bo Jiang, Xiangmin Shen, Beisha Tang, Chunyu Wang · 2019 · Journal of Clinical Neuroscience
  62. Extracellular α‐synuclein enters dopaminergic cells by modulating flotillin‐1–assisted dopamine transporter endocytosis
    Junpei Kobayashi, Takafumi Hasegawa, Naoto Sugeno, Shun Yoshida, Tetsuya Akiyama, Koki Fujimori, Hiroyasu Hatakeyama, Yasuo Miki, Arata Tomiyama, Yasushi Kawata et al. · 2019 · The FASEB Journal
  63. Compulsive eating behaviors in Parkinson’s disease
    I. de Chazeron, Franck Durif, Isabelle Chéreau, Maria Livia Fantini, Ana Marquès, Philippe Derost, Bérengère Debilly, Georges Brousse, Yves Boirie‌, Pierre‐Michel Llorca · 2019 · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity
  64. Protocol for a randomized, placebo-controlled, double-blind phase IIa study of the safety, tolerability, and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with Parkinson’s disease (ROCK-PD)
    A. Wolff, H. Bidner, Yvonne Remane, J. Zimmer, D. Aarsland, O. Rascol, Richard K. Wyse, A. Hapfelmeier, P. Lingor · 2024 · Frontiers in Aging Neuroscience
  65. Cannabidiol Protects Dopaminergic-like Neurons against Paraquat- and Maneb-Induced Cell Death through Safeguarding DJ-1CYS106 and Caspase 3 Independently of Cannabinoid Receptors: Relevance in Parkinson’s Disease
    Miguel Mendivil‐Perez, Andrea A. Felizardo-Otalvaro, Marlene Jiménez-Del-Río, Carlos Velez‐Pardo · 2023 · ACS Chemical Neuroscience
  66. How Organ-on-a-Chip Technology Can Assist in Studying the Role of the Glymphatic System in Neurodegenerative Diseases
    Sarah Spitz, Eunkyung Clare Ko, Peter Ertl, Roger Dale Kamm · 2023 · International Journal of Molecular Sciences
  67. Characterisation of functional deficits induced by AAV overexpression of alpha-synuclein in rats
    Francesco Gubinelli, Livija Sarauskyte, Chiara Venuti, Ida Kulacz, Giovanna Cazzolla, Matilde Negrini, Danish Anwer, I. Vecchio, F. Jakobs, Fredric P. Manfredsson et al. · 2022 · Current Research in Neurobiology
  68. LRRK2 and Proteostasis in Parkinson’s Disease
    María Dolores Pérez‐Carrión, Inmaculada Posadas, Javier Solera, Valentı́n Ceña · 2022 · International Journal of Molecular Sciences
  69. Post-Translational Modification of Cav1.2 and its Role in Neurodegenerative Diseases
    Yun Li, Hong Yang, Tianhan He, Liang Zhang, Chao Liu · 2022 · Frontiers in Pharmacology
  70. A review of dementia, focusing on the distinct roles of viral protein corona and MMP9 in dementia: Potential pharmacotherapeutic priorities
    Siva Prasad Panda, Urvashi Soni · 2022 · Ageing Research Reviews
  71. DJ-1 Protein and Its Role in the Development of Parkinson’s Disease: Studies on Experimental Models
    О.А. Бунеева, Alexey E. Medvedev · 2021 · Biochemistry (Moscow)
  72. Current State-of-the-Art and Unresolved Problems in Using Human Induced Pluripotent Stem Cell-Derived Dopamine Neurons for Parkinson’s Disease Drug Development
    Stanislav A. Antonov, Ekaterina V. Novosadova · 2021 · International Journal of Molecular Sciences
  73. Multi-Electrode Array Analysis Identifies Complex Dopamine Responses and Glucose Sensing Properties of Substantia Nigra Neurons in Mouse Brain Slices
    Nadja Mannal, Katharina Kleiner, Michael Fauler, Antonios Dougalis, Christina Pötschke, Birgit Liss · 2021 · Frontiers in Synaptic Neuroscience
  74. The efficacy and safety of moderate aerobic exercise for patients with Parkinson’s disease: a systematic review and meta-analysis of randomized controlled trials
    Yang Li, Hongling Song, Lihua Shen, Yanan Wang · 2021 · Annals of Palliative Medicine
  75. When does postural instability appear in monogenic parkinsonisms? An individual-patient meta-analysis
    Luca Marsili, Joaquín A. Vizcarra, Andrea Sturchio, Alok Kumar Dwivedi, Elizabeth G. Keeling, Dhiren Patel, Murli Mishra, Ashar M. Farooqi, Aristide Merola, Alfonso A. Fasano et al. · 2020 · Journal of Neurology
  76. Parkinson’s disease: what the model systems have taught us so far
    Swagata Ghatak, Dorit Trudler, Nima Dolatabadi, Rajesh Ambasudhan · 2018 · Journal of Genetics
  77. Leveraging Sequence-based Faecal Microbial Community Survey Data to Identify Alterations in Gut Microbiota among Patients with Parkinson’s Disease
    Ji, Tianyi, Huang, Hongyan, Liu, Jiaxuan, Peng, Tian, Zhou, Xiazhu, Tan, Qin, Yuan, Jiaguo, Hua, Huan, Ding, Songtao, Liu, Handeng · 2021 · European Journal of Neuroscience
  78. Unlocking the Epigenetic Symphony: Histone Acetylation’s Impact on Neurobehavioral Change in Neurodegenerative Disorders
    Balapal S. Basavarajappa, Shivakumar Subbanna · 2024 · Epigenomics
  79. Communal interaction of glycation and gut microbes in diabetes mellitus, Alzheimer's disease, and Parkinson's disease pathogenesis
    Rahul Shivaji Patil, Rashmi Santosh Tupe · 2023 · Medicinal Research Reviews
  80. Serotonin 5-HT1A receptors and their interactions with adenosine A2A receptors in Parkinson's disease and dyskinesia.
    A. Pinna, Pathik Parekh, M. Morelli · 2023 · Neuropharmacology
  81. Measuring the Usability of eHealth Solutions for Patients With Parkinson Disease: Observational Study
    Jonas Bendig, Anja Spanz, Jana Leidig, Anika K. Frank, Marcus Stahr, Heinz Reichmann, Kai F. Loewenbrück, Björn H. Falkenburger · 2022 · JMIR Formative Research
  82. Inactivation mode of sodium channels defines the different maximal firing rates of conventional versus atypical midbrain dopamine neurons
    Christopher J. Knowlton, Tabea Ines Ziouziou, Niklas Hammer, Jochen Roeper, Carmen C. Canavier · 2021 · PLoS Computational Biology
  83. microRNA signatures in prodromal REM sleep behavior disorder and early Parkinson's disease as noninvasive biomarkers
    Ricardo Titze‐de‐Almeida, Simoneide Souza Titze-de-Almeida, Gabriel Ginani Ferreira, Andrezza Paula Brito Silva, Pedro Renato de Paula Brandão, Wolfgang Hermann Oertel, Carlos Hugh Schenck, Raimundo Nonato Delgado Rodrigues · 2021 · Sleep Medicine
  84. PINK1 and Parkin: The odd couple
    Edgar D. Yoboue, Enza Maria Valente · 2020 · Neuroscience Research
  85. NCS-1 Deficiency Affects mRNA Levels of Genes Involved in Regulation of ATP Synthesis and Mitochondrial Stress in Highly Vulnerable Substantia nigra Dopaminergic Neurons
    Carsten Simons, J. Benkert, Nora Deuter, C. Poetschke, O. Pongs, T. Schneider, J. Duda, B. Liss · 2019 · Frontiers in Molecular Neuroscience
  86. Cysteamine as a novel disease-modifying compound for Parkinson's disease: Over a decade of research supporting a clinical trial
    Francesca Cicchetti, Linda Suzanne David, Alberto Siddu, Hélèna L. Denis · 2019 · Neurobiology of Disease
  87. Transplantation of Nurr1‐overexpressing neural stem cells and microglia for treating parkinsonian rats
    Qian Yuan, Xiaoxiang Chen, Wei Wang, Jun‐Jun Li, Xian‐Peng Wang, Zhiwei Tang, Jiao‐Tian Xu, Hai Yan Lin, Zhi‐Yong Yang, Liyan Li et al. · 2019 · CNS Neuroscience & Therapeutics
  88. Prenatal exposure to oxidative phosphorylation xenobiotics and late-onset Parkinson disease
    Eldris Iglesias, Alba Pesini, Nuria Garrido-Pérez, Patricia Meade, M. Pilar Bayona‐Bafaluy, Julio Montoya, Eduardo Ruiz‐Pesini · 2018 · Ageing Research Reviews
  89. Immunologic Treatment of Parkinson’s Disease
    Joseph J. Jankovic · 2017 · Immunotherapy
  90. Past, present, and future of Parkinson's disease
    O. Gershanik · 2017 · Movement Disorders
  91. Sensor‐integrated brain‐on‐a‐chip platforms: Improving the predictive validity in neurodegenerative research
    Sarah Spitz, Silvia Schobesberger, Konstanze Brandauer, Peter Ertl · 2023 · Bioengineering & Translational Medicine
  92. Externally validated deep learning model to identify prodromal Parkinson’s disease from electrocardiogram
    I. Karabayir, Fatma Gunturkun, Liam R. Butler, S. Goldman, R. Kamaleswaran, Robert L. Davis, K. Colletta, L. Chinthala, J. Jefferies, Kathleen L. Bobay et al. · 2023 · Scientific Reports
  93. Perturbation of serine enantiomers homeostasis in the striatum of MPTP-lesioned monkeys and mice reflects the extent of dopaminergic midbrain degeneration
    Marcello Serra, A. di Maio, V. Bassareo, T. Nuzzo, F. Errico, Federica Servillo, M. Capasso, Pathik Parekh, Qin Li, Marie-Laure Thiolat et al. · 2023 · Neurobiology of Disease
  94. Efficacy and safety of selegiline for the treatment of Parkinson's disease: A systematic review and meta-analysis
    Ke Wang, Zehui Liu, Xinya Li, Yanfei Li, Jia-Rui Li, Jiao-Jiao Hui, Jing-Xuan Li, Junwen Zhou, Zhan‐Miao Yi · 2023 · Frontiers in Aging Neuroscience
  95. Insights Into the Role of Mortalin in Alzheimer’s Disease, Parkinson’s Disease, and HIV-1-Associated Neurocognitive Disorders
    Priyanka, Pankaj Seth · 2022 · Frontiers in Cell and Developmental Biology
  96. Systematic analysis of the molecular mechanisms mediated by coffee in Parkinson’s disease based on network pharmacology approach
    Fangjun Li, Taku Hatano, Nobutaka Hattori · 2021 · Journal of Functional Foods
  97. How much time is needed in clinical practice to reach a diagnosis of clinically established Parkinson's disease?
    M. Rossi, S. Pérez-Lloret, M. Merello · 2021 · Parkinsonism & Related Disorders
  98. Ensemble of Deep Transfer Learning Models for Parkinson's Disease Classification
    Kiranbabu Rajanbabu, Iswarya Kannoth Veetil, V. Sowmya, E. Gopalakrishnan, K. Soman · 2021 · Advances in Intelligent Systems and Computing
  99. Attenuated Postprandial GLP-1 Response in Parkinson’s Disease
    Richard A. Manfready, Phillip A. Engen, Leo Verhagen Metman, Gabriella Sanzo, Christopher G. Goetz, Deborah A. Hall, Christopher B. Forsyth, Shohreh Raeisi, Robin M. Voigt, Ali Keshavarzian · 2021 · Frontiers in Neuroscience
  100. Distinct globus pallidus circuits regulate motor and cognitive functions
    A. Aristieta, A. Gittis · 2021 · Trends in Neurosciences